Citation: Peng Yu, Xiaodong Li, Guohui Cheng, Xu Zhang, Dan Wu, Jin Chang, Sheng Wang. Hydrogen peroxide-generating nanomedicine for enhanced chemodynamic therapy[J]. Chinese Chemical Letters, ;2021, 32(7): 2127-2138. doi: 10.1016/j.cclet.2021.02.015 shu

Hydrogen peroxide-generating nanomedicine for enhanced chemodynamic therapy

Peng Yu ^a ,
Xiaodong Li ^c ,
Guohui Cheng ^a ,
Xu Zhang ^a ,
Dan Wu ^{b, *,} ,
Jin Chang ^{a, *,} ,
Sheng Wang ^{a, *,}

a.
School of Life Sciences, Tianjin University, Tianjin 300072, China
b.
College of Chemical and Biological Engineering, Zhejiang University of Technology, Hangzhou 310014, China
c.
The Second Hospital, Tianjin Medical University, Tianjin 300211, China

danwu@zjut.edu.cn

jinchang@tju.edu.cn

shengwang@tju.edu.cn

Received Date: 2 November 2020
Revised Date: 8 February 2021
Accepted Date: 9 February 2021
Available Online: 11 February 2021

Figures(10)

Chemodynamic therapy (CDT) is an emerging endogenous stimulation activated tumor treatment approach that exploiting iron-containing nanomedicine as catalyst to convert hydrogen peroxide (H₂O₂) into toxic hydroxyl radical (^·OH) through Fenton reaction. Due to the unique characteristics (weak acidity and the high H₂O₂ level) of the tumor microenvironment, CDT has advantages of high selectivity and low side effect. However, as an important substrate of Fenton reaction, the endogenous H₂O₂ in tumor is still insufficient, which may be an important factor limiting the efficacy of CDT. In order to optimize CDT, various H₂O₂-generating nanomedicines that can promote the production of H₂O₂ in tumor have been designed and developed for enhanced CDT. In this review, we summarize recently developed nanomedicines based on catalytic enzymes, nanozymes, drugs, metal peroxides and bacteria. Finally, the challenges and possible development directions for further enhancing CDT are prospected.
- Nanomedicine,
- ROS,
- Chemodynamic therapy,
- Fenton reaction,
- Hydrogen peroxide
1. [1]
  J.P. Fruehauf, F.L. Meyskens, Clin. Cancer Res. 13 (2007) 789-794. doi: 10.1158/1078-0432.CCR-06-2082
2. [2]
  J. Noh, B. Kwon, E. Han, et al., Nat. Commun. 6 (2015) 6907. doi: 10.1038/ncomms7907
3. [3]
  G. Huang, H. Chen, Y. Dong, et al., Theranostics 3 (2013) 116-126. doi: 10.7150/thno.5411
4. [4]
  B.W. Yang, Y. Chen, J.L. Shi, Chem. Rev. 119 (2019) 4881-4985. doi: 10.1021/acs.chemrev.8b00626
5. [5]
  G. Yu, T.Y. Cen, Z. He, et al., Angew. Chem. Int. Ed. 58 (2019) 8799-8803. doi: 10.1002/anie.201903277
6. [6]
  S. Wang, R. Tian, X. Zhang, et al., Adv. Mater 33 (2021) 2007488. doi: 10.1002/adma.202007488
7. [7]
  S. Wang, G. Yu, W. Yang, et al., Adv. Sci. 8 (2021) 2002927. doi: 10.1002/advs.202002927
8. [8]
  Z. He, Y. Dai, X. Li, et al., Small 15 (2019) 1804131. doi: 10.1002/smll.201804131
9. [9]
  H. Ranji-Burachaloo, P.A. Gurr, D.E. Dunstan, G.G. Qiao, ACS Nano 12 (2018) 11819-11837. doi: 10.1021/acsnano.8b07635
10. [10]
  C. Zhang, W.B. Bu, D.L. Ni, et al., Angew. Chem. Int. Ed. 55 (2016) 2101-2106. doi: 10.1002/anie.201510031
11. [11]
  L. Lin, S. Wang, H. Deng, et al., J. Am. Chem. Soc. 142 (2020) 15320-15330. doi: 10.1021/jacs.0c05604
12. [12]
  J. Fang, T. Seki, H. Maeda, Adv. Drug Delivery Rev. 61 (2009) 290-302. doi: 10.1016/j.addr.2009.02.005
13. [13]
  D. Trachootham, J. Alexandre, P. Huang, Nat. Rev. Drug Discovery 8 (2009) 579-591. doi: 10.1038/nrd2803
14. [14]
  Z.M. Tang, Y.Y. Liu, M.Y. He, W.B. Bu, Angew. Chem. Int. Ed. 58 (2019) 946-956. doi: 10.1002/anie.201805664
15. [15]
  T.T. Wang, H. Zhang, H.H. Liu, et al., Adv. Funct. Mater. 30 (2020) 1906128. doi: 10.1002/adfm.201906128
16. [16]
  L.S. Lin, J.B. Song, L. Song, et al., Angew. Chem. Int. Ed. 57 (2018) 4902-4906. doi: 10.1002/anie.201712027
17. [17]
  C. Wang, Y.B. Liu, T. Zhou, et al., Chin. Chem. Lett. 30 (2019) 2231-2235. doi: 10.1016/j.cclet.2019.08.055
18. [18]
  J. Qu, T. Che, L. Shi, et al., Chin. Chem. Lett. 30 (2019) 1198-1203. doi: 10.1016/j.cclet.2019.01.021
19. [19]
  X. Yang, X. Cheng, A.A. Elzatahry, et al., Chin. Chem. Lett. 30 (2019) 324-330. doi: 10.1016/j.cclet.2018.06.026
20. [20]
  Y.H. Wang, W. Yin, W.D. Ke, et al., Biomacromolecules 19 (2018) 1990-1998. doi: 10.1021/acs.biomac.7b01777
21. [21]
  Z.M. Tang, H.L. Zhang, Y.Y. Liu, et al., Adv. Mater 29 (2017) 1701683. doi: 10.1002/adma.201701683
22. [22]
  Q. Guo, D. Wang, G. Yang, J. Biomed. Nanotechnol. 15 (2019) 2090-2099. doi: 10.1166/jbn.2019.2832
23. [23]
  W.P. Li, C.H. Su, Y.C. Chang, et al., ACS Nano 10 (2016) 2017-2027. doi: 10.1021/acsnano.5b06175
24. [24]
  M.F. Huo, L.Y. Wang, Y. Chen, J.L. Shi, Nat. Commun. 8 (2017) 357. doi: 10.1038/s41467-017-00424-8
25. [25]
  J.J. Li, A. Dirisala, Z.S. Ge, et al., Angew. Chem. Int. Ed. 56 (2017) 14025-14030. doi: 10.1002/anie.201706964
26. [26]
  C. Fang, Z. Deng, G.D. Cao, et al., Adv. Funct. Mater. 30 (2020) 1910085. doi: 10.1002/adfm.201910085
27. [27]
  L.L. Feng, R. Xie, C.Q. Wang, et al., ACS Nano 12 (2018) 11000-11012. doi: 10.1021/acsnano.8b05042
28. [28]
  S. Gao, H. Lin, H. Zhang, et al., Adv. Sci. 6 (2019) 1801733. doi: 10.1002/advs.201801733
29. [29]
  Z.G. Ren, S.C. Sun, R.R. Sun, et al., Adv. Mater 32 (2020) 1906024. doi: 10.1002/adma.201906024
30. [30]
  J.J. Liu, M. Wu, Y.T. Pan, et al., Adv. Funct. Mater. 30 (2020) 1908865. doi: 10.1002/adfm.201908865
31. [31]
  Y.L. Dai, Z. Yang, S.Y. Cheng, et al., Adv. Mater 30 (2018) 1704877. doi: 10.1002/adma.201704877
32. [32]
  R.K. Kankala, C.G. Liu, A.Z. Chen, et al., ACS Biomater. Sci. Eng. 3 (2017) 2431-2442. doi: 10.1021/acsbiomaterials.7b00569
33. [33]
  K. Sun, Z.G. Gao, Y. Zhang, et al., J. Mater. Chem. B Mater. Biol. Med. 6 (2018) 5876-5887. doi: 10.1039/C8TB01731J
34. [34]
  S. Wang, G.C. Yu, Z.T. Wang, et al., Angew. Chem. Int. Ed. 58 (2019) 14758-14763. doi: 10.1002/anie.201908997
35. [35]
  S. Wang, Z. Wang, G. Yu, et al., Adv. Sci. 6 (2019) 1801986. doi: 10.1002/advs.201801986
36. [36]
  N.Q. Gong, X.W. Ma, X.X. Ye, et al., Nat. Nanotechnol. 14 (2019) 379-387. doi: 10.1038/s41565-019-0373-6
37. [37]
  X.Y. Xu, Z.S. Zeng, J. Chen, et al., Chem. Eng. J. 390 (2020) 124628. doi: 10.1016/j.cej.2020.124628
38. [38]
  M. Zhang, R.X. Song, Y.Y. Liu, et al., Chem 5 (2019) 2171-2182. doi: 10.1016/j.chempr.2019.06.003
39. [39]
  S.C. Zhang, C.Y. Cao, X.Y. Lv, et al., Chem. Sci. 11 (2020) 1926-1934. doi: 10.1039/C9SC05506A
40. [40]
  L.S. Lin, T. Huang, J.B. Song, et al., J. Am. Chem. Soc. 141 (2019) 9937-9945. doi: 10.1021/jacs.9b03457
41. [41]
  L.S. Lin, J.F. Wang, J.B. Song, et al., Theranostics 9 (2019) 7200-7209. doi: 10.7150/thno.39831
42. [42]
  J.X. Fan, M.Y. Peng, H. Wang, et al., Adv. Mater 31 (2019) 1808278. doi: 10.1002/adma.201808278
43. [43]
  W. Fan, N. Lu, P. Huang, et al., Angew. Chem. Int. Ed. 56 (2017) 1229-1233. doi: 10.1002/anie.201610682
44. [44]
  M. Wang, D.M. Wang, Q. Chen, et al., Small 15 (2019) 1903895. doi: 10.1002/smll.201903895
45. [45]
  J.J. Li, Y.F. Li, Y.H. Wang, et al., Nano Lett. 17 (2017) 6983-6990. doi: 10.1021/acs.nanolett.7b03531
46. [46]
  H. Wei, E.K. Wang, Chem. Soc. Rev. 42 (2013) 6060-6093. doi: 10.1039/c3cs35486e
47. [47]
  M. Comotti, C. Della Pina, R. Matarrese, M. Rossi, Angew. Chem. Int. Ed. 43 (2004) 5812-5815. doi: 10.1002/anie.200460446
48. [48]
  J.N. Li, W.Q. Liu, X.C. Wu, X.F. Gao, Biomaterials 48 (2015) 37-44. doi: 10.1016/j.biomaterials.2015.01.012
49. [49]
  D. Hu, L. Chen, Y. Qu, et al., Theranostics 8 (2018) 1558-1574. doi: 10.7150/thno.22989
50. [50]
  Y.J. Sang, F.F. Cao, W. Li, et al., J. Am. Chem. Soc. 142 (2020) 5177-5183. doi: 10.1021/jacs.9b12873
51. [51]
  S. Ghosh, Bioorg. Chem. 88 (2019) 102925. doi: 10.1016/j.bioorg.2019.102925
52. [52]
  A. Brozovic, A. Ambriovic-Ristov, M. Osmak, Crit. Rev. Toxicol. 40 (2010) 347-359. doi: 10.3109/10408441003601836
53. [53]
  H.J. Kim, J.H. Lee, S.J. Kim, et al., J. Neurosci. 30 (2010) 3933-3946. doi: 10.1523/JNEUROSCI.6054-09.2010
54. [54]
  M. Ushio-Fukai, Y. Nakamura, Cancer Lett. 266 (2008) 37-52. doi: 10.1016/j.canlet.2008.02.044
55. [55]
  S.T. Duggan, G.M. Keating, Drugs 71 (2011) 2531-2558. doi: 10.2165/11207510-000000000-00000
56. [56]
  D.D. Von Hoff, M.W. Layard, P. Basa, et al., Ann. Intern. Med. 91 (1979) 710-717. doi: 10.7326/0003-4819-91-5-710
57. [57]
  X. Zhang, S. Wang, G. Cheng, et al., Matter 4 (2021) 26-53. doi: 10.1016/j.matt.2020.10.002
58. [58]
  S.D. Kan, W.M. Cheung, Y.L. Zhou, W.S. Ho, Planta Med. 80 (2014) 70-76. doi: 10.1055/s-0033-1360126
59. [59]
  M. Gilleron, X. Marechal, D. Montaigne, et al., Biochem. Biophys. Res. Commun. 388 (2009) 727-731. doi: 10.1016/j.bbrc.2009.08.085
60. [60]
  W.P. Tsang, S.P.Y. Chau, S.K. Kong, et al., Life Sci. 73 (2003) 2047-2058. doi: 10.1016/S0024-3205(03)00566-6
61. [61]
  A.B. Pardee, Y.Z. Li, C.J. Li, Curr. Cancer Drug Targets 2 (2002) 227-242. doi: 10.2174/1568009023333854
62. [62]
  D.C. Ferraz da Costa, L. Pereira Rangel, M. Martins-Dinis, et al., Molecules 25 (2020) 893. doi: 10.3390/molecules25040893
63. [63]
  X. Ma, X. Huang, G. Huang, et al., Adv. Healthcare Mater 3 (2014) 1210-1216. doi: 10.1002/adhm.201300590
64. [64]
  E. Blanco, E.A. Bey, C. Khemtong, et al., Cancer Res. 70 (2010) 3896-3904. doi: 10.1158/0008-5472.CAN-09-3995
65. [65]
  T.C. Huang, Y.L. Chung, M.L. Wu, S.M. Chuang, J. Agric. Food Chem. 59 (2011) 5164-5171. doi: 10.1021/jf200579h
66. [66]
  W. Yoo, D. Yoo, E. Hong, et al., J. Control. Release 269 (2018) 235-244. doi: 10.1016/j.jconrel.2017.11.023
67. [67]
  H. Ka, H.J. Park, H.J. Jung, et al., Cancer Lett. 196 (2003) 143-152. doi: 10.1016/S0304-3835(03)00238-6
68. [68]
  C.C. Huang, W.T. Chia, M.F. Chung, et al., J. Am. Chem. Soc. 138 (2016) 5222-5225. doi: 10.1021/jacs.6b01784
69. [69]
  Q. Li, L.H. Sun, M.M. Hou, et al., ACS Appl. Mater. Interfaces 11 (2019) 417-429. doi: 10.1021/acsami.8b19667
70. [70]
  Y.N. Dai, J.Z. Su, K. Wu, et al., ACS Appl. Mater. Interfaces 11 (2019) 10540-10553. doi: 10.1021/acsami.8b22748
71. [71]
  J.M. Pawelek, K.B. Low, D. Bermudes, Lancet Oncol. 4 (2003) 548-556. doi: 10.1016/S1470-2045(03)01194-X
72. [72]
  W.B. Coley, Ann. Surg. 14 (1891) 199-220. doi: 10.1097/00000658-189112000-00015
73. [73]
  D.E. Cameron, C.J. Bashor, J.J. Collins, Nat. Rev. Microbiol. 12 (2014) 381-390. doi: 10.1038/nrmicro3239
74. [74]
  P.N.L. Vo, H.M. Lee, D. Na, J. Microbiol. Biotechnol. 29 (2019) 845-855. doi: 10.4014/jmb.1904.04016
1. [1]
  Zhongyu Wang , Lijun Wang , Huaixin Zhao . DNA-based nanosystems to generate reactive oxygen species for nanomedicine. Chinese Chemical Letters, 2024, 35(11): 109637-. doi: 10.1016/j.cclet.2024.109637
2. [2]
  Zhaomin Tang , Qian He , Jianren Zhou , Shuang Yan , Li Jiang , Yudong Wang , Chenxing Yao , Huangzhao Wei , Keda Yang , Jiajia Wang . Active-transporting of charge-reversal Cu(Ⅱ)-doped mesoporous silica nanoagents for antitumor chemo/chemodynamic therapy. Chinese Chemical Letters, 2024, 35(7): 109742-. doi: 10.1016/j.cclet.2024.109742
3. [3]
  Yiqian Jiang , Zihan Yang , Xiuru Bi , Nan Yao , Peiqing Zhao , Xu Meng . Mediated electron transfer process in α-MnO₂ catalyzed Fenton-like reaction for oxytetracycline degradation. Chinese Chemical Letters, 2024, 35(8): 109331-. doi: 10.1016/j.cclet.2023.109331
4. [4]
  Liangliang Jia , Ye Hong , Xinyu He , Ying Zhou , Liujiao Ren , Hongjun Du , Bin Zhao , Bin Qin , Zhe Yang , Di Gao . Fighting hypoxia to improve photodynamic therapy-driven immunotherapy: Alleviating, exploiting and disregarding. Chinese Chemical Letters, 2025, 36(2): 109957-. doi: 10.1016/j.cclet.2024.109957
5. [5]
  Zekun Gao , Xiuli Zheng , Weimin Liu , Jie Sha , Shuaishuai Bian , Haohui Ren , Jiasheng Wu , Wenjun Zhang , Chun-Sing Lee , Pengfei Wang . GSH-activatable copper-elsinochrome off-on photosensitizer for combined specific NIR-Ⅱ two-photon photodynamic/chemodynamic therapy. Chinese Chemical Letters, 2025, 36(3): 109874-. doi: 10.1016/j.cclet.2024.109874
6. [6]
  Yating Zheng , Yulan Huang , Jing Luo , Xuqi Peng , Xiran Gui , Gang Liu , Yang Zhang . Supercritical fluid technology: A game-changer for biomacromolecular nanomedicine preparation and biomedical application. Chinese Chemical Letters, 2024, 35(7): 109169-. doi: 10.1016/j.cclet.2023.109169
7. [7]
  Qinyu Zhao , Yunchao Zhao , Songjing Zhong , Zhaoyang Yue , Zhuoheng Jiang , Shaobo Wang , Quanhong Hu , Shuncheng Yao , Kaikai Wen , Linlin Li . Urchin-like piezoelectric ZnSnO₃/Cu₃P p-n heterojunction for enhanced cancer sonodynamic therapy. Chinese Chemical Letters, 2024, 35(12): 109644-. doi: 10.1016/j.cclet.2024.109644
8. [8]
  Ke Gong , Jinghan Liao , Jiangtao Lin , Quan Wang , Zhihua Wu , Liting Wang , Jiali Zhang , Yi Dong , Yourong Duan , Jianhua Chen . Mitochondria-targeted nanoparticles overcome chemoresistance via downregulating BACH1/CD47 axis in ovarian carcinoma. Chinese Chemical Letters, 2024, 35(5): 108888-. doi: 10.1016/j.cclet.2023.108888
9. [9]
  Maosen Xu , Pengfei Zhu , Qinghong Cai , Meichun Bu , Chenghua Zhang , Hong Wu , Youzhou He , Min Fu , Siqi Li , Xingyan Liu . In-situ fabrication of TiO₂/NH₂−MIL-125(Ti) via MOF-driven strategy to promote efficient interfacial effects for enhancing photocatalytic NO removal activity. Chinese Chemical Letters, 2024, 35(10): 109524-. doi: 10.1016/j.cclet.2024.109524
10. [10]
  Mengfan Zhang , Lingyan Liu , Peng Wei , Wei Feng , Tao Yi . A proximity tagging strategy utilizing an activated aldehyde group as the active site. Chinese Chemical Letters, 2025, 36(4): 110127-. doi: 10.1016/j.cclet.2024.110127
11. [11]
  Zhi Li , Wenpei Li , Shaoping Jiang , Chuan Hu , Yuanyu Huang , Maxim Shevtsov , Huile Gao , Shaobo Ruan . Legumain-triggered aggregable gold nanoparticles for enhanced intratumoral retention. Chinese Chemical Letters, 2024, 35(7): 109150-. doi: 10.1016/j.cclet.2023.109150
12. [12]
  Wenjuan Jin , Zelong Chen , Yi Wang , Jiaxuan Li , Jiahui Li , Yuxin Pei , Zhichao Pei . Nano metal-photosensitizer based on Aza-BODIPY-Cu complex for CDT-enhanced dual phototherapy. Chinese Chemical Letters, 2024, 35(7): 109328-. doi: 10.1016/j.cclet.2023.109328
13. [13]
  Changzhu Huang , Wei Dai , Shimao Deng , Yixin Tian , Xiaolin Liu , Jia Lin , Hong Chen . A self-cleaning window for high-efficiency photodegradation of indoor formaldehyde. Chinese Chemical Letters, 2024, 35(9): 109429-. doi: 10.1016/j.cclet.2023.109429
14. [14]
  Yunkang Tong , Haiqiao Huang , Haolan Li , Mingle Li , Wen Sun , Jianjun Du , Jiangli Fan , Lei Wang , Bin Liu , Xiaoqiang Chen , Xiaojun Peng . Cooperative bond scission by HRP/H₂O₂ for targeted prodrug activation. Chinese Chemical Letters, 2024, 35(12): 109663-. doi: 10.1016/j.cclet.2024.109663
15. [15]
  Hao Lv , Zhi Li , Peng Yin , Ping Wan , Mingshan Zhu . Recent progress on non-metallic carbon nitride for the photosynthesis of H₂O₂: Mechanism, modification and in-situ applications. Chinese Chemical Letters, 2025, 36(1): 110457-. doi: 10.1016/j.cclet.2024.110457
16. [16]
  Shiyu Pan , Bo Cao , Deling Yuan , Tifeng Jiao , Qingrui Zhang , Shoufeng Tang . Complexes of cupric ion and tartaric acid enhanced calcium peroxide Fenton-like reaction for metronidazole degradation. Chinese Chemical Letters, 2024, 35(7): 109185-. doi: 10.1016/j.cclet.2023.109185
17. [17]
  Xiaoshuai Wu , Bailei Wang , Yichen Li , Xiaoxuan Guan , Mingjing Yin , Wenquan Lv , Yin Chen , Fei Lu , Tao Qin , Huyang Gao , Weiqian Jin , Yifu Huang , Cuiping Li , Ming Gao , Junyu Lu . NIR driven catalytic enhanced acute lung injury therapy by using polydopamine@Co nanozyme via scavenging ROS. Chinese Chemical Letters, 2025, 36(2): 110211-. doi: 10.1016/j.cclet.2024.110211
18. [18]
  Jingyu Cai , Xiaoyu Miao , Yulai Zhao , Longqiang Xiao . Exploratory Teaching Experiment Design of FeOOH-RGO Aerogel for Photocatalytic Benzene to Phenol. University Chemistry, 2024, 39(4): 169-177. doi: 10.3866/PKU.DXHX202311028
19. [19]
  Huijiao Fu , Peiqin Liang , Qianwen Chen , Yan Wang , Guang Li , Xuzi Cai , Shengtao Wang , Kun Chen , Shengying Shi , Zhiqiang Yu , Xuefeng Wang . COX-2 blocking therapy in cisplatin chemosensitization of ovarian cancer: An allicin-based nanomedicine approach. Chinese Chemical Letters, 2024, 35(8): 109241-. doi: 10.1016/j.cclet.2023.109241
20. [20]
  An Lu , Yuhao Guo , Yi Yan , Lin Zhai , Xiangyu Wang , Weiran Cao , Zijie Li , Zhixia Zhao , Yujie Shi , Yuanjun Zhu , Xiaoyan Liu , Huining He , Zhiyu Wang , Jian-Cheng Wang . Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy. Chinese Chemical Letters, 2024, 35(6): 108928-. doi: 10.1016/j.cclet.2023.108928

Get Citation

PDF

XML

Metrics

PDF Downloads(26)
Abstract views(1305)
HTML views(181)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142